Eli Lilly (LLY)

$720.52 11.68 (1.60%)

10:52 EDT LLY Stock Quote Delayed 30 Minutes

Don’t Miss Out! 3 Top-Tier Blue-Chip Growth Stocks for Your Must-Buy List

By Chris MacDonald, InvestorPlace Contributor Apr 25, 2024

These three large-cap blue-chip growth stocks are certainly worth considering as core portfolio holdings in this current environment.

Which Companies Will Join the Trillion-Dollar Team in 2024? Our 3 Best Guesses

7 High-Flying Stocks That Are Majorly Overdue for a Pullback

Strong Buy Alert: 7 No-Brainer Stocks to Scoop Up Now

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 930,046

Day's Range $718.30 - $727.99

52-Week Range $370.68 - $800.78

Dividend & Yield $4.52 (0.63%)

LLY Stock Predictions, Articles, and Eli Lilly News

From InvestorPlace
From the Web

7 A-Rated Aggressive Biotech Stocks to Bet On in 2024

By Louis Navellier and the InvestorPlace Research Staff Apr 12, 2024

We’re using the Portfolio Grader to find the best biotech stocks to buy in today’s market. Each of these stocks get top grades.

Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027

By Chris MacDonald, InvestorPlace Contributor Apr 12, 2024

For investors looking for a way to play weight-loss stocks in this current backdrop, here are three top options to consider right now.

Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for April 2024

By Joel Baglole, InvestorPlace Contributor Apr 11, 2024

Investors wanting to broaden and deepen their portfolio should reach for these healthcare names, each of which is a favorite among analysts.

Trillion-Dollar Trajectories: 3 Billion-Dollar Stocks With the Potential to Hit the Next Milestone

By Rick Orford, InvestorPlace Contributor Apr 11, 2024

Looking for your next picks? These top-performing market leaders have the potential to be the next trillion-dollar companies.

3 Obesity Drug Stocks Set to Skyrocket as Demand Goes Wild

By Shane Neagle, InvestorPlace Contributor Apr 10, 2024

Discover top obesity drug stocks set to soar as demand surges. Eli Lilly, Novo Nordisk, & Dexcom lead with revolutionary treatments

3 High-Growth Biotech Stocks Investors Shouldn’t Sleep On in April

By Chris MacDonald, InvestorPlace Contributor Apr 9, 2024

These high-growth biotech stocks are certainly worth considering for investors looking for market-beating returns in the long-term.

3 Growth Stocks with Even Greater Potential Than the Magnificent 7

By Chris MacDonald, InvestorPlace Contributor Apr 4, 2024

Here are three Magnificent 7 contenders growth investors shouldn't be sleeping on right now, given their long-term potential.

7 A-Rated Stocks to Buy in April

By Louis Navellier and the InvestorPlace Research Staff Apr 4, 2024

These A-rated stocks to buy for April will help you forget about the pain of tax season. Instead, enjoy the profits from these top stocks.

The 3 Best Healthcare Stocks to Buy in April 2024

By Michael Que, InvestorPlace Contributor Apr 3, 2024

The healthcare industry is not going to stop growing anytime soon. These are the best healthcare stocks to buy in April.

5 Healthcare Stocks to Buy for 2024

By Thomas Yeung, CFA, InvestorPlace Markets Analyst Apr 2, 2024

Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.

The 3 Best Biotech Stocks to Buy in Q2 2024

By Chandler Capital, InvestorPlace Contributor Mar 29, 2024

Biotech can be a risky industry for investors, but we've done the legwork for you with these three biotech stocks for Q2.

The 3 Biggest Beneficiaries of the Massive AI-Driven Growth Opportunities

By Larry Ramer, InvestorPlace Contributor Mar 28, 2024

These three names are the best positioned stocks to benefit from AI growth and will benefit from the technology in a variety of ways.

Hedge Funds Are Fleeing Tech: 7 Stocks They’re Buying Instead

By Josh Enomoto, InvestorPlace Contributor Mar 24, 2024

It doesn’t seem like it based on the mercurial valuations of certain innovators but a rotation away from technology could open doors for stocks hedge…

Hot Stocks: The 3 Best Opportunities for Investing in Weight Loss Drugs

By Chris MacDonald, InvestorPlace Contributor Mar 22, 2024

The market for weight loss drug stocks is massive, and these three companies could be the biggest beneficiaries of this trend.

3 Stocks Ready to Ride the Bull Higher

By Joel Baglole, InvestorPlace Contributor Mar 20, 2024

Each of these securities is rising on strong earnings prints and catalysts that could send their share prices upwards in coming months.

Wall Street’s Favorite Growth Stocks? 7 Names That Could Make You Filthy Rich

By Muslim Farooque, InvestorPlace Contributor Mar 18, 2024

Growth stocks should continue to rise as the S&P 500 hits new highs, with rate cuts on the horizon expected to continue fueling the rally.

The $1 Trillion Question: Will LLY, TSMC or TSLA Be Wall Street’s Next Nvidia?

By Dmytro Spilka, InvestorPlace Contributor Mar 17, 2024

While it's challenging to surpass the trillion dollar market capitalization mark, a few potentials are contending for the title.

The Trillion-Dollar Crystal Ball: 3 Companies Next in Line for the Market Milestone

By Rick Orford, InvestorPlace Contributor Mar 16, 2024

These three companies have the potential to cross over and become the next trillion-dollar stocks—so watch out.

3 Weight-Loss Stocks to Buy as GLP-1 Mania Takes Hold

By Chris Markoch, InvestorPlace Contributor Mar 15, 2024

If you want to take advantage of the red-hot growth in weight-loss stocks, these are three companies that you can own a piece of today.

7 Growth Stocks to Sell in March Before They Crash & Burn

By Ian Bezek, InvestorPlace Contributor Mar 14, 2024

Growth stocks are on fire to start 2024. But when the rally loses steam, these seven growth stocks to sell will come crashing down.

Eli Lilly (LLY)

Don’t Miss Out! 3 Top-Tier Blue-Chip Growth Stocks for Your Must-Buy List

Which Companies Will Join the Trillion-Dollar Team in 2024? Our 3 Best Guesses

7 High-Flying Stocks That Are Majorly Overdue for a Pullback

Strong Buy Alert: 7 No-Brainer Stocks to Scoop Up Now

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Eli Lilly (LLY)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

LLY Stock Predictions, Articles, and Eli Lilly News

Subscriber Sign in